Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures

Clinical Infectious Diseases

Volumn 47, Issue 10, 2008, Pages 1354-1357

  Rebeiro, Peter F ^a   Kheshti, Asghar ^a,b   Bebawy, Sally S ^a   Stinnette, Samuel E ^a   Erdem, Husamettin ^a   Tang, Yi Wei ^a   Sterling, Timothy R ^a   Raffanti, Stephen P ^a,b   D'Aquila, Richard T ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Comprehensive Care Center ^*  (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS DETECTION;

FREEZING; HIV INFECTIONS; HIV-1; HUMANS; PLASMA; RNA, VIRAL; SPECIMEN HANDLING; VIRAL LOAD;

EID: 54249156386     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592693     Document Type: Article

References (11)

1. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-54.
2. Gross R, Bilker WB, Friedman HM, Strom BL. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001; 15:2109-17.
3. Wood E, Yip B, Hogg RS, et al. Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy. AIDS 2000; 14:1955-60.
4. Roland ME, Carlson LL, Frassetto LA, Stock PG. Solid organ transplantation: referral, management, and outcomes in HIV-infected patients. AIDS Reader 2006; 16:664-8; 675-8.
5. AIDS Clinical Trials Group. Clinical trials: trials open to enrollment. 2008. Available at: http://www.aactg.org/clinicaltrials_research.asp. Accessed 15 April 2008.
6. Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep 2001; 50:63-85.
7. Sabino EC, Gaburo N Jr, Leite JP, Viecili M, Rosenfeld LG. Platelets may affect detection and quantitation of HIV RNA in plasma samples with low viral loads. J Acquir Immune Defic Syndr 2004; 37:1432-3.
8. Stosor V, Palella FJ Jr, Berzins B, et al. Transient viremia in HIV-infected patients and use of plasma preparation tubes. Clin Infect Dis 2005; 41:1671-4.
9. Salimnia H, Moore EC, Crane LR, MacArthur RD, Fairfax MR. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) standard and ultrasensitive assays caused by freezing patient plasma in centrifuged Becton-Dickinson Vacutainer brand plasma preparation tubes. J Clin Microbiol 2005; 43:4635-9.
10. García-Bujalance S, Ladrón de Guevara C, González-García J, Arribas JR, Zamora F, Gutiérrez A. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1. J Microbiol Methods 2007; 69:384-6.
11. Griffith BP, Mayo DR. Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in plasma preparation tubes (PPT). J Clin Virol. 2006; 35:197-200.